Zu "274693-27-5" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Ticagrelor
Artikelnummer: TGM-T0179-100mg
Description: Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20,...
| Schlagworte: | AR-C 126532XX, AZD6140 |
| CAS | 274693-27-5 |
| MW: | 522.57 D |
ab 40,00 €
Ticagrelor
Artikelnummer: Cay15425-5
Ticagrelor is a reversible antagonist of the platelet purinergic P2Y12 receptor (Ki = 14 nM, IC50 = 1.8 µM), which is the main receptor responsible for ADP-induced platelet aggregation. It functions by directly changing the conformation of the P2Y12 receptor to inhibit ADP binding. Formulations containing ticagrelor...
| Schlagworte: | AR-C 126532XX, AZD 6140,... |
| Anwendung: | P2Y12 receptor antagonist |
| CAS | 274693-27-5 |
| MW: | 522.6 D |
ab 43,00 €
Ticagrelor
Artikelnummer: LKT-T3200.5
Ticagrelor is a platelet aggregation inhibitor. It is a nucleoside analogue and blocks adenosine diphosphate (ADP) receptors of subtype P2Y12. In contrast to the other antiplatelet drugs, ticagrelor has a binding site different from ADP, making it an allosteric antagonist, and the blockage is reversible. The drug...
| Schlagworte: | AZD-6140, (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-... |
| Anwendung: | P2Y12 receptor antagonist |
| CAS | 274693-27-5 |
| MW: | 522.57 D |
ab 77,00 €
